lifestyle.theglimpse.com

Author: Reviva Pharmaceuticals

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

April 23, 2026
Reviva Announces Letter to Shareholders

April 15, 2026
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights

March 30, 2026
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering

March 23, 2026
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering

March 18, 2026
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

March 18, 2026